[The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
The authors report on the last 100 cases of intervention in which thyroid pathology has been used and also prove how, in their experience, thyroglobulin is an MO, highly specific for CDT. In some cases its dosage changes even in the course of benign thyroid pathology but the value has never exceeded, in these cases, twice the norm. This also confirms, therefore the importance of this MO for the follow up of patients operated on using CDT.
Gerardi
G
G
Divisione di Chirurgia d'Urgenza, USL n. 44, Ospedale Ascalesi, Napoli.
De Angelis
P
P
D018263:Adenocarcinoma, Follicular / Q000097:blood* / Q000453:epidemiology / Q000601:surgery; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D002291:Carcinoma, Papillary / Q000097:blood* / Q000453:epidemiology / Q000601:surgery; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood* / Q000453:epidemiology / Q000601:surgery; D013965:Thyroidectomy
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D013954:Thyroglobulin
Utilizzazione clinica dei markers oncologici nella patologia neoplastica della tiroide. Nostra esperienza.